SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,943,000 | +120.8% | 63,084 | +49.5% | 0.01% | +33.3% |
| Q3 2020 | $880,000 | -70.1% | 42,185 | -65.9% | 0.01% | -68.4% |
| Q2 2020 | $2,939,000 | +528.0% | 123,732 | +376.6% | 0.02% | +375.0% |
| Q1 2020 | $468,000 | -65.0% | 25,963 | -54.0% | 0.00% | -33.3% |
| Q4 2019 | $1,339,000 | -90.6% | 56,440 | -89.1% | 0.01% | -92.6% |
| Q3 2019 | $14,197,000 | -14.5% | 516,643 | +3.0% | 0.08% | -21.4% |
| Q2 2019 | $16,605,000 | +4.7% | 501,783 | +10.9% | 0.10% | +83.9% |
| Q1 2019 | $15,858,000 | +188.6% | 452,586 | +173.6% | 0.06% | +5.7% |
| Q4 2018 | $5,495,000 | +51.8% | 165,413 | +109.2% | 0.05% | +194.4% |
| Q1 2018 | $3,621,000 | +177.5% | 79,058 | +141.5% | 0.02% | +157.1% |
| Q4 2017 | $1,305,000 | +178.8% | 32,740 | +116.8% | 0.01% | +75.0% |
| Q1 2017 | $468,000 | – | 15,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |